InteliCare Holdings Limited (ICR) AI Stock Analysis

• Market Cap: AU$2.93M
• Dividend Yield: N/A
• Average Volume (3M): 1.01M
• Price to Earnings (P/E): ―
• Beta (1Y): -0.06
• Revenue Growth: 73.53%
• EPS Growth: -7.35%
• Country: AU
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 487,890,660
• 10 Day Avg. Volume: 1,985,622
• 30 Day Avg. Volume: 1,008,273
• PEG Ratio: -0.08
• Price to Book (P/B): 4.20
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 34 Underperform
• Price Target: ―

InteliCare Holdings Limited's overall stock score reflects significant financial challenges, including persistent losses, negative equity, and cash flow difficulties. The absence of technical analysis data and a negative P/E ratio further highlight the company's unattractive investment profile. Major improvements in financial performance and strategic direction are needed to enhance stock appeal.

InteliCare Holdings Limited Business Overview & Revenue Model

Company Description

InteliCare Holdings Limited (ICR) is a technology company operating in the health and aged care sectors. The company is primarily focused on developing and commercializing smart technology solutions designed to assist in the remote monitoring and management of elderly and disabled individuals. Its core products include the InteliLiving system, which integrates sensors and artificial intelligence to provide real-time insights and alerts to caregivers and family members, enhancing the safety and independence of those needing care.

How the Company Makes Money

InteliCare Holdings Limited generates revenue through the sale and subscription of its technology solutions, primarily the InteliLiving system. The company offers these products directly to consumers as well as to aged care providers and healthcare facilities. Revenue streams include one-time sales of hardware devices, such as sensors and monitoring equipment, and ongoing subscription fees for access to its software platform and data analytics services. Additionally, InteliCare may engage in partnerships with healthcare providers and institutions to expand its market reach and enhance product offerings, contributing to its revenue growth.

InteliCare Holdings Limited Financial Statement Overview

Summary

InteliCare Holdings Limited exhibits several financial challenges across its statements. The income statement shows persistent losses and negative margins, indicating difficulty in achieving profitability. The balance sheet is weak, with negative equity and a high liability position relative to assets, posing significant financial risk. The cash flow statement highlights ongoing cash flow difficulties, with consistent negative free cash flow and operating cash flow. Overall, the financial health of the company is poor, requiring significant improvements in revenue generation, cost control, and cash management to enhance financial stability and sustainability.

Income Statement

The income statement reveals consistent negative net income and gross profit over the years. The gross profit margin is negative due to higher costs than revenue. Revenue has shown volatility with a significant decline in the latest year, indicating an unstable growth trajectory. The net profit margin remains negative, suggesting ongoing challenges in achieving profitability. Overall, the income statement indicates significant room for improvement in financial performance.

Balance Sheet

The balance sheet shows a concerning negative stockholders' equity, indicating liabilities exceed assets, which is a significant risk factor. The company has a negative equity ratio, and the debt-to-equity ratio is not applicable due to negative equity. The return on equity is also negative, highlighting the company's inability to generate returns for shareholders. Overall, the balance sheet suggests financial instability and potential risks due to the high level of liabilities.

Cash Flow

The cash flow statement shows persistent negative operating cash flow, indicating challenges in generating cash from operations. Free cash flow is consistently negative, reflecting the company's struggle to cover capital expenditures and operational costs with its cash generation. The operating cash flow to net income ratio is not favorable, suggesting inefficiencies in turning income into cash. Overall, the cash flow statement highlights significant cash management challenges.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
658.63K	280.29K	404.35K	429.85K	363.12K	267.54K
	Gross Profit
-1.42M	-1.79M	-2.69M	-2.75M	-1.99M	-1.27M
	EBIT
-2.88M	-3.11M	-4.05M	-4.75M	-4.91M	-2.60M
	EBITDA
-2.22M	-3.02M	-2.92M	-3.78M	-4.24M	-2.47M
	Net Income Common Stockholders
-2.37M	-2.26M	-3.00M	-3.93M	-4.36M	-2.55M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.41M	834.20K	1.94M	2.27M	2.67M	4.20M
	Total Assets
1.88M	1.52M	2.48M	2.88M	3.43M	4.78M
	Total Debt
305.90K	545.39K	726.57K	18.25K	85.16K	144.58K
	Net Debt
-1.10M	-288.80K	-1.21M	-2.25M	-2.59M	-4.05M
	Total Liabilities
954.67K	1.69M	1.53M	1.34M	842.64K	753.63K
	Stockholders Equity
926.52K	-168.32K	949.11K	1.54M	2.59M	4.02M
Cash Flow		Free Cash Flow
-1.84M	-1.66M	-3.11M	-3.14M	-3.86M	-1.68M
	Operating Cash Flow
-1.84M	-1.66M	-3.10M	-3.10M	-3.79M	-1.57M
	Investing Cash Flow
-3.10K	0.00	-14.35K	-32.92K	-74.79K	-108.55K
	Financing Cash Flow
1.69M	555.65K	2.78M	2.73M	2.34M	5.83M

InteliCare Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ARA	61 Neutral	AU$93.57M	20.51	2.75%	2.08%	11.31%	―
Sector *	54 Neutral	$5.31B	3.28	-45.10%	2.80%	16.76%	0.02%
VHL	45 Neutral	AU$67.81M	―	-185.67%	―	492.19%	12.16%
BDX	43 Neutral	AU$25.25M	―	-104.23%	―	―	-17.26%
CYP	43 Neutral	AU$38.41M	―	-75.39%	―	―	44.29%
ICR	34 Underperform	AU$2.93M	―	-309.52%	―	73.53%	-7.35%

InteliCare Holdings Limited Corporate Events

InteliCare Expands Aged Care Partnerships with New Trials and Deployments

InteliCare Holdings Ltd has announced a new commercial agreement with mecwacare to trial its InteliCare platform at the Trescowthick Centre in Victoria, marking a significant step in its strategy to expand partnerships with large aged care providers. The company is also progressing with deployments at Hardi Aged Care facilities, with integration into Hardi’s systems expected soon. These developments, alongside strategic partnerships with other health technology providers, position InteliCare to capitalize on growth opportunities in the evolving aged care sector, particularly with upcoming changes in the Aged Care Act and the Support at Home Program.

InteliCare Holdings Limited Reports Quarterly Cash Flow Results

InteliCare Holdings Limited reported its quarterly cash flow results, highlighting a net cash decrease from operating activities amounting to $447,000 and a slight reduction from investing activities at $2,000. Despite these operational cash flow challenges, the company experienced a positive cash flow from financing activities, resulting in a net increase in cash and cash equivalents for the period. This financial update suggests that while operational and investment cash flows are currently negative, the company is leveraging financing activities to maintain liquidity, which could impact its future strategic decisions and stakeholder confidence.

InteliCare Partners with mecwacare for Digital Transformation Trial

InteliCare Holdings Ltd has entered into a commercial agreement with mecwacare to trial its InteliCare solution at the Trescowthick Centre in Prahran, Victoria. This trial is part of mecwacare’s digital transformation strategy to become a leading technology-enabled care provider in Victoria. The three-month trial, which involves a $212k investment in hardware and implementation services, aims to assess the potential for broader deployment across mecwacare’s facilities. The collaboration is expected to enhance mecwacare’s service delivery and provide valuable insights into resident care, aligning with InteliCare’s commercialisation strategy and strengthening its position in the aged care sector.

InteliCare Reports Increased Losses and Decline in Asset Value for H2 2024

InteliCare Holdings Limited reported a 16.7% increase in its loss from ordinary activities after tax, amounting to $772,513 for the half-year ended December 31, 2024. The company did not declare any dividends during this period. The net tangible assets per ordinary security decreased from 0.39 cents in the previous period to 0.13 cents in the current reporting period, indicating a decline in asset value, which may impact investor confidence.

InteliCare Ensures Compliance with Performance Rights Issuance

InteliCare Holdings Limited has issued a notice under section 708A(5) of the Corporations Act regarding the issuance of performance rights that can be converted into fully paid ordinary shares. The company confirms compliance with relevant provisions of the Corporations Act and asserts that no information has been excluded from its continuous disclosure obligations. This announcement assures stakeholders of InteliCare’s adherence to legal requirements and transparency in its financial disclosures, which may impact investor confidence and market perception.

InteliCare Holdings: Director’s Interest Update

InteliCare Holdings Limited announced a change in the interests of its director, Neale Fong. The company disclosed that Fong has acquired 9,000,000 additional performance rights, increasing his total holding to 14,000,000 performance rights and maintaining 3,000,000 unlisted options. This move, approved by shareholders, signifies confidence in Fong’s leadership and could potentially influence investor perception positively given the increase in his stake in the company.